Content Handbook H
Outline of method
Tebuconazole is separated from manufacturing impurities and added modifying agents by TLC. The area containing the active ingredient is removed and the active ingredient is eluted from the removed silica gel with methanol. After evaporating the solvent the residual is used for IR.
The method is suitable for technical solutions and formulationscontaining more than 1.0 % of active ingredient.
The method is usable for TC, WG, EW, SC, FS and ES-formulations.